ANTITUMOR EFFECT POTENTIATOR - NAT CEREBRAL & CARDIOVASCULAR CT

Title:

ANTITUMOR EFFECT POTENTIATOR

Document Type and Number:

WIPO Patent Application WO/2020/067170

Kind Code:

A1

Abstract:

Provided is a novel means for activating an immune response in tumor immunotherapy in which an immune checkpoint inhibitor is used. An immune-checkpoint-inhibitor antitumor effect potentiator having probiotics and prebiotics as active ingredients.

More Like This:

JP5210299	Production method of antimutagenic substances using lactic acid bacteria
JP6058223	The constituent for phosphorus uptake control
JP5832297	Compositions containing probiotic and prebiotic components as well as inorganic salts with lactoferrin

Inventors:

KANGAWA KENJI (JP)
NOJIRI TAKASHI (JP)
KUMAZOE MOTOFUMI (JP)
TANAKA YASUTAKE (JP)
SHISHIDO YOSHIYUKI (JP)
ASAHARA TAKASHI (JP)
MIURA TAKAHITO (JP)
TANIGUCHI KEISUKE (JP)

Application Number:

PCT/JP2019/037623

Publication Date:

April 02, 2020

Filing Date:

September 25, 2019

Export Citation:

Click for automatic bibliography generation Help

Assignee:

NAT CEREBRAL & CARDIOVASCULAR CT (JP)
YAKULT HONSHA KK (JP)

International Classes:

A61K35/747; A23C15/00; A23L2/00; A23L2/02; A23L2/38; A23L2/52; A23L33/135; A61K31/702; A61K35/745; A61K39/395; A61K45/00; A61P35/00; A61P37/04; A61P43/00

Domestic Patent References:

WO2011005335A1

2011-01-13

Foreign References:

JP2018521013A	2018-08-02
JP2002241292A	2002-08-28
JP2016529912A	2016-09-29
JP2015536155A	2015-12-21
JP5885764B2	2016-03-15

Other References:

ASAHARA, TAKASHI: "The usefulness of synbiotics in the perioperative period", ANNUAL REPORT OF THE YAKULT INSTITUTE FOR MICROBIOLOGICAL RESEARCH, vol. 35, 20 March 2017 (2017-03-20), pages 11 - 19, XP009526852, ISSN: 0285-032X
See also references of EP 3858368A4

Attorney, Agent or Firm:

THE PATENT CORPORATE BODY ARUGA PATENT OFFICE (JP)

Download PDF:

View/Download PDF PDF Help

Previous Patent: ELECTROCHEMICAL DEVICE

Next Patent: METHOD FOR MEASURING BLOOD COAGULATION TIME